Oncoceutics, Inc.
ClosedPhiladelphia, United States · Founded 2015
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- oncoceutics.com
- Last Round
- Series AJul 2015
- Rounds
- 1
About
Oncoceutics is a clinical-stage biotechnology company discovering small-molecule drugs that engage tumor-suppressor pathways in cancer. Its lead compound, ONC201, is an imipridone shown to selectively induce cell death across multiple cancer types and advanced through clinical trials for indications including recurrent glioblastoma. Founded by Dr. Wafik El-Deiry, the Philadelphia-based company was acquired by Chimerix in 2021, which continued developing ONC201 toward FDA approval.
Summary
Oncoceutics, Inc. is a Biotech company based in Philadelphia, United States, founded in 2015. Its most recent funding was a Series A round in Jul 2015. Investors include Spring Mountain Capital.
Funding History
Jan 2021
Sign up to see all 2 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/oncoceutics-inc"><img src="https://indexed.vc/api/badge/company/oncoceutics-inc" alt="Oncoceutics, Inc. on Indexed.vc" width="260" height="76" /></a>